Blood clots, or thrombosis, are a central mechanism behind several serious cardiovascular and vascular events, including ischemic stroke, pulmonary embolism, and myocardial infarction (heart attack). A “blood clot” forms when components of blood—including platelets and fibrin—assemble inappropriately within blood vessels. Depending on where the clot forms (arteries vs veins), it can produce different clinical syndromes: arterial thrombosis more commonly underlies stroke and heart attack, whereas venous thromboembolism more commonly underlies deep vein thrombosis (DVT) and pulmonary embolism (PE).
After age 40, baseline risk for these events generally increases due to a combination of biological aging, cumulative exposure to risk factors, and changes in vascular structure and function. Aging is associated with endothelial dysfunction, chronic low-grade inflammation, altered coagulation balance (a tendency toward hypercoagulability), increased arterial stiffness, and reduced physiologic resilience to stressors. Importantly, risk is not “normal” in the sense of harmless; rather, it is statistically more frequent, which is why clinicians emphasize preventive strategies and early symptom recognition.
Mechanistically, arterial events (stroke and heart attack) typically involve rupture or erosion of atherosclerotic plaque. When plaque destabilizes, platelets adhere, activate, and aggregate, while the coagulation cascade generates fibrin, producing an occlusive thrombus. This can abruptly cut off blood flow to brain tissue or the heart muscle. Risk factors that accelerate atherosclerosis include hypertension, diabetes, dyslipidemia, smoking, chronic kidney disease, and inflammatory conditions. Lifestyle patterns—sedentary behavior, poor diet, and obesity—also contribute through insulin resistance and inflammatory pathways.
Venous thromboembolism (DVT and PE) arises more from stasis and hypercoagulability than from plaque rupture. Virchow’s triad (venous stasis, endothelial injury, and hypercoagulability) explains many cases. Immobilization (including long travel or hospitalization), major surgery, trauma, active malignancy, pregnancy/postpartum physiology, estrogen-containing medications, and inherited thrombophilias all increase risk. A clot in the venous system can dislodge and travel to the pulmonary arteries, causing impaired oxygenation and strain on the right side of the heart. PE can be life-threatening, particularly when it is massive or submassive.
A key point in public health communication is differentiating age-related baseline risk from specific iatrogenic (treatment-related) or event-related risks. When clinicians evaluate claims that vaccine-related clots are responsible for increased events, the appropriate question is: what is the magnitude of risk, what is the relevant diagnosis, and what is the causal pathway? For some vaccines, rare immune-mediated conditions have been reported—most notably vaccine-induced immune thrombotic thrombocytopenia (VITT). VITT is characterized by thrombosis at unusual sites (such as cerebral venous sinus thrombosis or splanchnic vein thrombosis) combined with thrombocytopenia and anti-platelet factor 4 (PF4) antibodies that activate platelets through an immune mechanism. This resembles heparin-induced thrombocytopenia (HIT) in clinical logic but occurs without prior heparin exposure. Timing after vaccination—often within days to a few weeks—helps distinguish VITT from typical age-related thrombosis.
Nevertheless, in the general population, the majority of strokes, PEs, and heart attacks are explained by common cardiovascular and thromboembolic risk factors rather than rare immune syndromes. Most people who experience these events are older and have multiple baseline risk factors. Therefore, clinical interpretation requires absolute risk assessment rather than focusing on relative fear. Public health decisions weigh benefits (especially prevention of severe infectious outcomes) against rare adverse events and then guide surveillance, diagnosis, and treatment protocols.
Clinically, symptoms matter. Possible stroke warning signs include sudden facial droop, arm weakness, speech difficulty, or severe dizziness—often summarized as BE FAST. PE may present with sudden shortness of breath, pleuritic chest pain, cough (sometimes with blood), tachycardia, or unexplained fainting. Heart attack symptoms include chest pressure, pain radiating to the arm/jaw, sweating, nausea, and shortness of breath. Any suspected event warrants emergency evaluation.
Diagnosis typically uses imaging and laboratory testing. Stroke assessment commonly involves urgent brain imaging (CT or MRI). PE evaluation uses CT pulmonary angiography or ventilation/perfusion scanning, complemented by D-dimer in selected contexts. Myocardial infarction is diagnosed with ECG patterns and serial cardiac biomarkers (e.g., troponin). In suspected VITT, clinicians obtain platelet counts, coagulation studies, PF4 antibody testing, and tailored treatment.
Treatment differs by mechanism: arterial occlusions often require antiplatelet therapy and reperfusion when feasible, while venous thromboembolism requires anticoagulation. For VITT, management involves non-heparin anticoagulation, immunomodulation (commonly intravenous immunoglobulin), and avoidance of platelet transfusions unless specifically indicated due to thrombocytopenia and thrombosis risk.
Finally, prevention focuses on modifiable drivers: controlling blood pressure and diabetes, optimizing lipids, smoking cessation, weight management, physical activity, and addressing transient immobilization. For individuals with prior DVT/PE or known thrombophilia, tailored risk stratification and prophylaxis strategies are essential.
Source: [@ABridgen] (X post, Jun 2, 2026)
Andrew Bridgen: Are the MSM trying to programme us to accept that blood clots resulting in strokes, pulmonary embolisms and heart attacks are normal after 40 ? Is this because heart attack ,stroke and pulmonary embolism risk is increased after Covid vaccination ?. #breaking
— @ABridgen May 1, 2026
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
